Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar 13 vaccine against atherosclerosis
NL-OMON21732Active, not recruiting
- Sponsor
- N.A.
- Start
- Apr 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of pneumococcal 13-valent conjugate vaccine in atherosclerosis, sponsored by N.A. Started Apr 2016; status: active, not recruiting.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NL-OMON21732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21732.